BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 517 filers reported holding BIO-TECHNE CORP in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,525,370 | -38.7% | 1,329,886 | -26.5% | 0.01% | -33.3% |
| Q2 2023 | $147,604,834 | -45.1% | 1,808,218 | -50.1% | 0.01% | 0.0% |
| Q1 2023 | $268,973,882 | +102.7% | 3,625,474 | +126.4% | 0.01% | -7.7% |
| Q4 2022 | $132,724,908 | +20.5% | 1,601,411 | +313.0% | 0.01% | +18.2% |
| Q3 2022 | $110,110,000 | -4.8% | 387,714 | +16.2% | 0.01% | -8.3% |
| Q2 2022 | $115,672,000 | -18.9% | 333,694 | +1.3% | 0.01% | +9.1% |
| Q1 2022 | $142,663,000 | +11.4% | 329,446 | +33.1% | 0.01% | +22.2% |
| Q4 2021 | $128,029,000 | -28.0% | 247,474 | -32.5% | 0.01% | -35.7% |
| Q3 2021 | $177,777,000 | +26.5% | 366,876 | +17.6% | 0.01% | +27.3% |
| Q2 2021 | $140,502,000 | -2.1% | 312,047 | -16.9% | 0.01% | -8.3% |
| Q1 2021 | $143,490,000 | +978.7% | 375,698 | +796.9% | 0.01% | +1100.0% |
| Q4 2020 | $13,302,000 | +26.7% | 41,890 | -1.2% | 0.00% | 0.0% |
| Q3 2020 | $10,502,000 | +812.4% | 42,396 | +873.1% | 0.00% | – |
| Q2 2020 | $1,151,000 | +765.4% | 4,357 | +522.4% | 0.00% | – |
| Q1 2020 | $133,000 | -98.4% | 700 | -98.1% | 0.00% | -100.0% |
| Q4 2019 | $8,118,000 | +12.2% | 36,986 | +0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,235,000 | +238.7% | 36,978 | +261.0% | 0.00% | – |
| Q2 2019 | $2,136,000 | +5.3% | 10,242 | +0.3% | 0.00% | – |
| Q1 2019 | $2,028,000 | +1234.2% | 10,211 | +869.7% | 0.00% | – |
| Q4 2018 | $152,000 | -32.4% | 1,053 | -4.4% | 0.00% | – |
| Q3 2018 | $225,000 | -60.4% | 1,102 | -76.6% | 0.00% | – |
| Q3 2017 | $568,000 | +51.5% | 4,700 | +25.7% | 0.00% | – |
| Q1 2015 | $375,000 | -3.1% | 3,738 | -10.9% | 0.00% | – |
| Q4 2014 | $387,000 | – | 4,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 300,000 | $24,489,000 | 21.05% |
| Montanaro Asset Management Ltd | 388,800 | $31,737,744 | 5.02% |
| Sandhill Capital Partners LLC | 502,447 | $41,014,775 | 3.74% |
| Brown Capital Management | 3,160,892 | $258,023,614 | 3.66% |
| DF DENT & CO INC | 3,275,617 | $267,388,640 | 3.62% |
| Ownership Capital B.V. | 2,282,104 | $186,288,150 | 3.26% |
| Jackson Square Partners, LLC | 1,361,789 | $111,162,836 | 3.24% |
| STONE RUN CAPITAL, LLC | 88,135 | $7,194,460 | 3.20% |
| Pembroke Management, LTD | 339,591 | $27,720,813 | 2.99% |
| Summit Creek Advisors LLC | 283,693 | $23,157,860 | 2.90% |